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Modeling the Expected Cost-effectiveness and 
Impact of Oral Pre-exposure Prophylaxis in 
Uganda and Swaziland 
Clinical trials have shown that oral antiretrovirals 
(ARVs) containing tenofovir/emtricitabine used by 
HIV-negative individuals to prevent HIV acquisition, 
called oral pre-exposure prophylaxis (PrEP), are 
safe and effective in several populations. Oral 
PrEP is now considered part of the PEPFAR HIV 
prevention toolkit, and procurement by PEPFAR 
is permitted in countries where (1) test and start 
policies have been initiated; (2) viral load testing 
policies call for testing at least annually; and (3) 
multi-month ARV provision is available for stable 
clients. 
Prior modeling work has demonstrated that oral 
PrEP is most cost effective when targeted to 
populations at very high risk of infection, with 
risk dependent on a combination of individual 
behavior and epidemic contexts. Project SOAR is 
assisting Uganda and Swazilandi in making critical 
decisions about oral PrEP introduction and scale 
up by modelling the expected cost-effectiveness 
iPrEP modelling is also being conducted in Mozambique and Lesotho 
through Health Policy Plus (HP+). 
and impact of oral PrEP within each country’s 
larger portfolio of HIV prevention interventions. 
OUR RESEARCH 
The Project SOAR team first worked with country 
stakeholders to identify specific modeling 
questions that would be helpful to advance 
PrEP policy and implementation planning and 
discussions in-country (see box on next page 
for Uganda’s questions). SOAR then adapted, 
expanded, and applied existing modeling tools 
to estimate the expected cost-effectiveness and 
impact of oral PrEP within the larger portfolio of 
HIV prevention interventions. The modeling tools 
used are the Goals Model and the Incidence 
Patterns Model (IPM), which uses published 
data in Demographic and Health Surveys (DHS), 
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Modelling the expected cost effectiveness and impact 
of oral PrEP within Uganda and Swaziland’s portfolio 
of HIV interventions will help each country make 
critical decisions about oral PrEP.
Population-based HIV Impact Assessments (PHIA) 
and AIDS Indicator Surveys (AIS) to estimate HIV 
incidence in each risk group and province. These 
two models are then combined into a single 
platform to create the Oral PrEP Workbook—a 
Microsoft Excel-based tool that links the IPM with 
Goals and visualizes the results to address policy 
questions raised in each country. 
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RESEARCH UTILIZATION
SOAR, in consultation with the USAID Missions, 
is presenting their analytical findings in-country 
to stakeholders within the Ministries of Health 
and National AIDS Control Programs in Swaziland 
and Uganda. The purpose of these meetings is to 
discuss the implications of PrEP in each country 
and design a strategy for moving forward. 
What would Uganda like to know from 
PrEP modelling?
	How would rolling out oral PrEP to different 
risk groups and geographic areas affect the 
impact, cost-effectiveness, and total cost of 
oral PrEP?
	How do the impact, cost, and cost 
effectiveness vary by risk group?
	Female sex workers 
	Serodiscordant couples
	Men who have sex with men 
	People who inject drugs 
	Adolescent girls and young women with 
multiple partners 
	How would varying levels of future scale-
up of ART and voluntary medical male 
circumcision affect the impact and cost-
effectiveness of oral PrEP?
	How would varying unit costs of oral PrEP 
by risk group affect the relative cost- 
effectiveness of providing PrEP to the 
different risk groups?
	How would varying levels of adherence by 
risk group affect the relative impact and 
cost-effectiveness of providing PrEP to the 
different risk groups?
Strengths of our modelling approach
	Combines the more detailed risk structure 
of IPM with the dynamic projections and HIV 
interventions in the Goals Model.
	Incorporates risk groups not previously 
modeled in Goals: serodiscordant couples, 
adolescent girls and young women.
	Dynamic modeling can take into account 
projected changes in HIV incidence from 
scaling up ART and other HIV prevention 
interventions.
	Use of rigorous data from published DHS, 
PHIA and AIS surveys to disaggregate HIV 
incidence by risk group.
	Oral PrEP Workbook allows users flexibility in 
defining rates and levels of scale-up of PrEP, 
target populations, unit costs, etc. while 
automating the communication between the 
IPM and Goals Model.
